UAB Molecule data Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 5,790 |
| 5,790 |
| 19,062 |
| -19,062 |
| -19,062 |
| -245.85 |
| -329.22 |
| 938 |
| 1,081 |
| 0 |
| 2,009 |
| 0.16 |
| 1.15 |
| - |
| - |
| -245.85 |
| -14,235 |
| 2023 |
|---|
| 10,328 |
| 10,328 |
| 2,400 |
| 2,292 |
| 2,292 |
| 28.84 |
| 22.19 |
| 3,230 |
| 2,031 |
| 0 |
| 5,261 |
| 0.31 |
| 0.63 |
| - |
| - |
| 28.84 |
| 2,979 |
| 2024 |
|---|
| 12,955 |
| 12,955 |
| 6,802 |
| 6,496 |
| 6,496 |
| 53.72 |
| 50.14 |
| 9,726 |
| 1,390 |
| 0 |
| 11,116 |
| 0.75 |
| 0.14 |
| - |
| - |
| 53.72 |
| 6,959 |
| 2024 |
|---|
| 12,955 |
| 12,955 |
| 6,802 |
| 6,496 |
| 6,496 |
| 53.72 |
| 50.14 |
| 9,726 |
| 1,390 |
| 0 |
| 11,116 |
| 0.75 |
| 0.14 |
| - |
| - |
| 53.72 |
| 6,959 |
Turnover (€)
2024
Turnover (€)
12,955 €25 % *
Sales per employee (€)
12,955 €25 % *
Profit before tax (€)
6,802 €183 % *
Net Profit (€)
6,496 €183 % *
Profit per employee (€)
6,496 €183 % *
Total profitability (%)
53.72 %86.27 % *
Net profitability (%)
50.14 %125.96 % *
Equity (€)
9,726 €201 % *
Amounts Payable And Liabilities (€)
1,390 €-32 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
11,116 €111 % *
Working capital requirement
0.75 141.94 % *
Debt-to-equity ratio
0.14 -77.78 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
53.72 %86.27 % *
EBIT (€)
6,959 €134 % *
